生科新闻, 更新时间: 2005年11月30日
  由美国生科集团 (BVTech, Inc.) 主办
  
台湾无照生产禽流感药物
2005-11-30

尽管没有获得瑞士Roche制药公司的执照, 台湾仍决定生产抗病毒药物Tamiflu用于抗禽流感。Roche星期五说它将提供台湾所要求的所有Tamiflu, 拒绝了台湾自己生产药物以供地方使用的执照申请。台湾当局对这一决定感到失望, 为补充Roche获得的药物它已授权海岛卫生部制造Tamiflu以供居民使用。官员说Tamiflu的生产能继续到2007 年12月31 日。但如果台湾与Roche 达成专利协议, 这一授权将被取消。台湾说如果自制药物在Roche批准前使用将讨论补偿该公司。


Taiwan To Produce Bird Flu Drug Without License From Roche

Taiwan has decided to go ahead with production of the anti-viral drug Tamiflu for use against bird flu despite its failure to obtain a license from Swiss pharmaceutical giant Roche. Roche said Friday it would supply Taiwan with all the Tamiflu it required and turned down its request for a license to produce the drug itself for local use. That decision disappointed Taiwanese authorities, who granted the island's Department of Health permission to manufacture Tamiflu for resident use only, to supplement drugs obtained from Roche. Officials said production of Tamiflu could go on until December 31, 2007, but that permission would be revoked should Taiwan reach a subsequent patent agreement with Roche. Taiwan said it would discuss compensation for Roche if the home-produced drug were used prior to approval from the company.

(See Story from AFP)


 

Bioinformatics, sequence analysis; GCG; Life Science News; Drug Discovery.
生命科学进展新闻网
生科新闻网是反映生命科学研究进展的新闻网站。致力于为学术界和工业界的生命科学研究人员和大专院校师生提供及时, 准确的新闻和研究动态。为促进科技交流,尽其绵薄之力。
This is a web site of life science news in Chinese. It provides news and research trens in life sciences and drug discovery. This site is updated continuously throughout the day.